Goncalves, Antonio Pedro <br/><br/>
Synergistic growth inhibition of cancer cells harboring the RET/PTC1 oncogene by staurosporine and rotenone involves enhanced cell death.  [electronic resource] 

 -  Journal of biosciences  Sep 2011 
 - 639-48 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0973-7138 
<br/><br/><label>Standard No.: </label>10.1007/s12038-011-9100-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Blotting, Western<br/>Carcinoma<br/>Carcinoma, Papillary--drug therapy<br/>Cell Cycle Checkpoints--drug effects<br/>Cell Death--drug effects<br/>Cell Division--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Drug Synergism<br/>Flow Cytometry<br/>Fluorescent Antibody Technique<br/>Humans<br/>Oncogene Proteins, Fusion--genetics<br/>Patched Receptors<br/>Proto-Oncogene Proteins c-ret--genetics<br/>Receptors, Cell Surface--genetics<br/>Rotenone--pharmacology<br/>Staurosporine--pharmacology<br/>Thyroid Cancer, Papillary<br/>Thyroid Gland--drug effects<br/>Thyroid Neoplasms--drug therapy